Re-negotiation on benefit recovery and PVA negotiation related to pharmaceuticals with the brain functional improvement agent "Choline alfoscerate" have emerged as variables.

On the 3rd, the MOHW ordered the NHIS to conduct negotiations on 123 items of Choline alfoscerate for 40 days from June 4 to July 13.

Choline alfoscerate recovery negotiations, which began on December 14 last year, have been under way four times so far, and 123 items from 58 final companies have not been agreed on. The pharmaceutical industry is questioning the effectiveness of the fourth round of negotiations that will be held again after failing to reach an agreement over the past six months. The NHIS considered th